The implementation of a biomedical cellular product — the transfer of a biomedical cellular product on a paid basis and (or) on a non-paid basis[1]. [1] Federal Law No. 180-FZ dated 23.06.2016 "On Biomedical Cellular Products". 2016, as amended on 01.01.2017, Article 2, subpara. 2.